Continuous glucose monitoring systems give contact dermatitis in children and adults despite efforts of providing less ‘allergy‐ prone’ devices: investigation and advice hampered by insufficient material for optimized patch test investigations
Open Access
- 8 October 2020
- journal article
- research article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 35 (3) , 730-737
Abstract
Background: Medical devices are increasingly being reported to cause contact allergic dermatitis reactions.Objective: Review of patients with diabetes type I referred for suspected allergic contact dermatitis to insulin pump or glucose sensor systems. Method: We have reviewed 11 referred diabetes mellitus patients investigated for allergic contact dermatitis reactions to medical devices and specifically Dexcom G6®. Extracts from the medical devices were analysed.Results: The majority of patients was children, the majority had relevant allergies and particularly allergy to isobornyl acrylate which was also found in the glucose sensor system Dexcom G6®.Conclusions: The following case reports bring in focus the fact that patients sensitized through use of one medical device and being advised the use of another, or find another product for a while useful, are not by necessity free from future episodes of allergic contact dermatitis. The case reports emphasize the need for collaboration since it is impossible for even well‐equipped laboratories to properly investigate the medical devices when information on the substances used in production is not uniform and complete and material to investigate are scarce. The importance of adequate patch test series and testing with own material and furthermore the importance to re‐analyse medical devices and re‐analyse test data are emphasized.Keywords
This publication has 29 references indexed in Scilit:
- Allergic contact dermatitis caused by 2‐ethyl cyanoacrylate contained in glucose sensor sets in two diabetic adultsContact Dermatitis, 2017
- Manufacturing Process Changes and Reduced Skin Irritations of an Adhesive Patch Used for Continuous Glucose Monitoring DevicesJournal of Diabetes Science and Technology, 2017
- Allergic contact dermatitis caused by isobornyl acrylate in Freestyle® Libre, a newly introduced glucose sensorContact Dermatitis, 2017
- Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trialThe Lancet Diabetes & Endocrinology, 2016
- European Society of Contact Dermatitis guideline for diagnostic patch testing – recommendations on best practiceContact Dermatitis, 2015
- Tracking of Metabolic Control from Childhood to Young Adulthood in Type 1 DiabetesThe Journal of Pediatrics, 2014
- A high mean-HbA1c value 3-15 months after diagnosis of type 1 diabetes in childhood is related to metabolic control, macroalbuminuria, and retinopathy in early adulthood-a pilot study using two nation-wide population based quality registriesPediatric Diabetes, 2013
- Flare-up reactions after oral challenge with nickel in relation to challenge dose and intensity and time of previous patch test reactionsJournal of the American Academy of Dermatology, 2001
- Patch testing with colophony at 60% concentrationContact Dermatitis, 1986
- Allergic contact dermatitis to epoxy resin in infusion sets of an insulin pumpContact Dermatitis, 1985